- Home
- DLO vs PRCT Comparison
DLO vs PRCT Comparison
Compare DLO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLO
- PRCT
- Stock Information
- Founded
- DLO 2013
- PRCT 2009
- Country
- DLO Uruguay
- PRCT United States
- Employees
- DLO N/A
- PRCT N/A
- Industry
- DLO Business Services
- PRCT Medical Specialities
- Sector
- DLO Consumer Discretionary
- PRCT Health Care
- Exchange
- DLO Nasdaq
- PRCT Nasdaq
- Market Cap
- DLO 2.5B
- PRCT 2.9B
- IPO Year
- DLO 2021
- PRCT 2021
- Fundamental
- Price
- DLO $8.70
- PRCT $53.03
- Analyst Decision
- DLO Hold
- PRCT Strong Buy
- Analyst Count
- DLO 9
- PRCT 7
- Target Price
- DLO $11.94
- PRCT $91.43
- AVG Volume (30 Days)
- DLO 690.8K
- PRCT 1.0M
- Earning Date
- DLO 05-14-2025
- PRCT 04-24-2025
- Dividend Yield
- DLO N/A
- PRCT N/A
- EPS Growth
- DLO N/A
- PRCT N/A
- EPS
- DLO 0.39
- PRCT N/A
- Revenue
- DLO $745,974,000.00
- PRCT $224,498,000.00
- Revenue This Year
- DLO $30.04
- PRCT $46.28
- Revenue Next Year
- DLO $26.70
- PRCT $32.67
- P/E Ratio
- DLO $22.31
- PRCT N/A
- Revenue Growth
- DLO 14.70
- PRCT 64.84
- 52 Week Low
- DLO $6.58
- PRCT $47.04
- 52 Week High
- DLO $15.75
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- DLO 45.49
- PRCT 42.69
- Support Level
- DLO $7.61
- PRCT $51.27
- Resistance Level
- DLO $8.88
- PRCT $54.75
- Average True Range (ATR)
- DLO 0.49
- PRCT 3.64
- MACD
- DLO 0.13
- PRCT 0.19
- Stochastic Oscillator
- DLO 69.47
- PRCT 49.48
About DLO DLocal Limited
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables global enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.